Textron Inc (TXT) shareholders
Close on Nov 17, 2026Market cap $13.83BP/E 14.7Yield 0.10%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| Abigail P. Johnson Joint filing with FMR LLC (10.10%) | 17,336,158 | 10.10% | 13G (passive) amendment | Jul 31, 2026 |
| BlackRock, Inc. | 16,727,725 | 8.50% | 13G (passive) amendment | Dec 31, 2023 |
| Vanguard Capital Management | 13,018,492 | 7.47% | 13G (passive) | Mar 31, 2026 |
| FMR LLC Joint filing with Abigail P. Johnson (6.50%) | 11,402,382 | 6.50% | 13G (passive) | Mar 31, 2026 |
| State Street Corporation | 9,220,909 | 5.20% | 13G (passive) | Sep 30, 2025 |
| Invesco Ltd. | 8,853,800 | 5.10% | 13G (passive) | Sep 30, 2026 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of TXT | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| FMR LLC | 16,084,547 | 9.50% | $1.48B | +4,682,165 | 0.06% |
| BlackRock, Inc. | 15,634,200 | 9.23% | $1.43B | −23,878 | 0.02% |
| Vanguard Capital Management LLC | 11,385,818 | 6.72% | $1.04B | +50,571 | 0.02% |
| State Street Corp | 9,830,439 | 5.80% | $901.94M | +86,141 | 0.03% |
| Invesco Ltd. | 8,514,210 | 5.03% | $781.01M | +503,257 | 0.06% |
| Vanguard Portfolio Management LLC | 7,392,538 | 4.36% | $678.12M | −92,417 | 0.03% |
| Boston Partners | 6,116,780 | 3.61% | $561.07M | +393,895 | 0.50% |
| Geode Capital Management, LLC | 5,085,135 | 3.00% | $480.65M | +112,735 | 0.03% |
| Aqr Capital Management LLC | 4,658,243 | 2.75% | $422.74M | −975,033 | 0.15% |
| Lsv Asset Management | 4,595,936 | 2.71% | $421.59M | +522,709 | 0.77% |
| T. Rowe Price Investment Management, Inc. | 4,364,655 | 2.58% | $400.37M | −815,553 | 0.26% |
| Dimensional Fund Advisors LP | 2,604,534 | 1.54% | $238.89M | +50,596 | 0.04% |
| Price T Rowe Associates Inc /Md/ | 2,599,185 | 1.53% | $238.42M | +187,099 | 0.02% |
| Brandes Investment Partners, LP | 2,521,792 | 1.49% | $231.33M | −318,961 | 1.62% |
| Morgan Stanley | 2,368,734 | 1.40% | $217.28M | −207,322 | 0.01% |
| JPMorgan Chase & Co | 1,850,824 | 1.09% | $166.85M | −659,578 | 0.01% |
| Goldman Sachs Group Inc | 1,836,234 | 1.08% | $168.44M | −14,620 | 0.01% |
| Charles Schwab Investment Management Inc | 1,720,929 | 1.02% | $157.86M | +2,698 | 0.02% |
| Northern Trust Corp | 1,518,618 | 0.90% | $139.30M | −20,131 | 0.02% |
| Gamco Investors, Inc. Et Al | 1,278,399 | 0.75% | $117.27M | −13,781 | 1.05% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 789 | 159M | 93.8% | 96 / 279 | 267 / 86 | 13M | 10M |
| Q1 2026 | 792 | 156M | 91.9% | 112 / 283 | 247 / 63 | 35M | 20M |
| Q4 2025 | 756 | 161M | 95.0% | 142 / 270 | 217 / 56 | 18M | 13M |
| Q3 2025 | 684 | 156M | 92.1% | 91 / 243 | 206 / 59 | 12M | 13M |
| Q2 2025 | 660 | 157M | 92.4% | 100 / 239 | 217 / 79 | 12M | 9M |
| Q1 2025 | 647 | 154M | 91.0% | 82 / 209 | 243 / 88 | 11M | 12M |
| Q4 2024 | 658 | 156M | 92.2% | 81 / 191 | 274 / 100 | 10M | 17M |
| Q3 2024 | 690 | 163M | 96.3% | 70 / 224 | 253 / 52 | 22M | 7M |
| Q2 2024 | 676 | 164M | 96.9% | 69 / 219 | 258 / 88 | 6M | 14M |
| Q1 2024 | 700 | 172M | 100.0% | 110 / 241 | 221 / 49 | 10M | 10M |
| Q4 2023 | 647 | 173M | 100.0% | 126 / 214 | 202 / 44 | 16M | 9M |
| Q3 2023 | 572 | 167M | 98.5% | 82 / 173 | 200 / 65 | 9M | 13M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
663 funds held TXT in Q2 2026, 47% of their shares through ETFs. Each fund counts once per quarter, from its quarter-end report.
| Fund | Shares | % of TXT | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 5,522,906 | 3.26% | $506.62M | 0.02% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 4,506,824 | 2.66% | $413.41M | 0.02% | Jun 30, 2026 |
| Vanguard Small-Cap Index Fund | 3,987,460 | 2.35% | $365.77M | 0.19% | Jun 30, 2026 |
| Strategic Advisers Fidelity U.S. Total Stock Fund | 3,246,230 | 1.92% | $297.87M | 0.12% | May 31, 2026 |
| Disciplined Value Mid Cap Fund | 2,904,407 | 1.71% | $266.42M | 1.15% | Jun 30, 2026 |
| Vanguard Small-Cap Value Index Fund | 2,526,217 | 1.49% | $231.73M | 0.34% | Jun 30, 2026 |
| iShares Core S&P 500 ETF | 2,391,799 | 1.41% | $219.40M | 0.02% | Jun 30, 2026 |
| T. Rowe Price Mid-Cap Growth Fund, Inc. | 2,295,196 | 1.35% | $210.54M | 0.91% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 2,228,763 | 1.32% | $204.51M | 0.02% | May 31, 2026 |
| Invesco Comstock Fund | 2,125,300 | 1.25% | $181.20M | 1.21% | Jul 31, 2026 |
| Invesco S&P 500 Equal Weight ETF | 2,040,045 | 1.20% | $173.93M | 0.18% | Jul 31, 2026 |
| State Street(R) SPDR(R) S&P(R) Aerospace & Defense ETF | 1,823,180 | 1.08% | $167.24M | 2.59% | Jun 30, 2026 |
| iShares U.S. Aerospace & Defense ETF | 1,761,813 | 1.04% | $161.61M | 1.12% | Jun 30, 2026 |
| Fidelity Series Value Discovery Fund | 1,586,700 | 0.94% | $135.28M | 0.76% | Jul 31, 2026 |
| Fidelity Low-Priced Stock Fund | 1,382,484 | 0.82% | $117.87M | 0.47% | Jul 31, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Scott C. Donnelly | Executive Chairman, Director | 743,222 | 0.44% | Mar 3, 2026 |
| Lisa M. Atherton | President and CEO, Director | 56,518 | 0.03% | Mar 3, 2026 |
| David Mathew Rosenberg | Executive Vice President & CFO | 16,179 | 0.01% | Mar 3, 2026 |
| E. Robert Lupone | EVP, General Counsel & Secy | 113,625 | 0.07% | Mar 3, 2026 |
| Mark S. Bamford | VP & Corporate Controller | 9,391 | 0.01% | Mar 3, 2026 |
| Julie G. Duffy | EVP and CHRO | 52,494 | 0.03% | Mar 3, 2026 |
| Frank T. Connor | Executive Vice President & CFO | 186,122 | 0.11% | Jan 6, 2025 |
| R. Kerry Clark | Director | 8,611 | 0.01% | May 7, 2026 |
| Michael X. Garrett | Director | 8,598 | 0.01% | May 1, 2026 |
| Richard F. Ambrose | Director | 11,302 | 0.01% | May 1, 2026 |
| Robert Mionis | Director | 5,176 | 0.00% | May 1, 2026 |
| Echevarria Maria Cristina Mendez | Director | 2,439 | 0.00% | May 1, 2026 |
| Thomas A. Kennedy | Director | 20,162 | 0.01% | May 1, 2026 |
| Lionel L. Nowell Iii | Director | 20,493 | 0.01% | May 1, 2026 |
| Maria T. Zuber | Director | 20,558 | 0.01% | May 1, 2026 |
| Deborah L. James | Director | 20,505 | 0.01% | May 1, 2026 |
| Kathleen M. Bader | Director | 6,650 | 0.00% | Apr 25, 2025 |
| James L. Ziemer | Director | 15,791 | 0.01% | Apr 2, 2025 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| R. Kerry Clark Director | May 6, 2026 | Sale | −2,517 | $93.09 | $234.31K | 8,611 |
| Thomas A. Kennedy Director | May 1, 2026 | Buy | +10,300 | $95.98 | $988.59K | 20,162 |
| Richard F. Ambrose Director | Apr 29, 2026 | Award | +2,061 | – | – | 11,302 |
| Echevarria Maria Cristina Mendez Director | Apr 29, 2026 | Award | +2,061 | – | – | 2,439 |
| Michael X. Garrett Director | Apr 29, 2026 | Award | +2,061 | – | – | 8,598 |
| Lionel L. Nowell Iii Director | Apr 29, 2026 | Award | +2,061 | – | – | 20,493 |
| Robert Mionis Director | Apr 29, 2026 | Award | +2,061 | – | – | 5,176 |
| Deborah L. James Director | Apr 29, 2026 | Award | +2,061 | – | – | 20,505 |
| Thomas A. Kennedy Director | Apr 29, 2026 | Award | +2,061 | – | – | 9,862 |
| Maria T. Zuber Director | Apr 29, 2026 | Award | +2,061 | – | – | 20,558 |
| R. Kerry Clark Director | Apr 29, 2026 | Award | +2,061 | – | – | 11,128 |
| David Mathew Rosenberg Executive Vice President & CFO | Mar 1, 2026 | Award | +6,102 | – | – | 14,253 |
| E. Robert Lupone EVP, General Counsel & Secy | Mar 1, 2026 | Tax withholding | −2,423 | $98.65 | $239.03K | 107,155 |
| E. Robert Lupone EVP, General Counsel & Secy | Mar 1, 2026 | Award | +5,587 | – | – | 109,578 |
| Scott C. Donnelly Executive Chairman, Director | Mar 1, 2026 | Tax withholding | −19,777 | $98.65 | $1.95M | 735,658 |
| Scott C. Donnelly Executive Chairman, Director | Mar 1, 2026 | Award | +13,017 | – | – | 755,435 |
| Mark S. Bamford VP & Corporate Controller | Mar 1, 2026 | Award | +1,296 | – | – | 9,168 |
| Mark S. Bamford VP & Corporate Controller | Mar 1, 2026 | Tax withholding | −564 | $98.65 | $55.64K | 8,604 |
| Lisa M. Atherton President and CEO, Director | Mar 1, 2026 | Award | +27,118 | – | – | 54,059 |
| Lisa M. Atherton President and CEO, Director | Mar 1, 2026 | Tax withholding | −2,008 | $98.65 | $198.09K | 52,051 |
| Julie G. Duffy EVP and CHRO | Mar 1, 2026 | Tax withholding | −1,864 | $98.65 | $183.88K | 39,091 |
| Julie G. Duffy EVP and CHRO | Mar 1, 2026 | Award | +3,916 | – | – | 40,955 |
| E. Robert Lupone EVP, General Counsel & Secy | Feb 17, 2026 | Option exercise | +28,056 | $49.58 | $1.39M | 132,047 |
| E. Robert Lupone EVP, General Counsel & Secy | Feb 17, 2026 | Sale | −28,056 | $98.84 | $2.77M | 103,991 |
| Mark S. Bamford VP & Corporate Controller | Feb 17, 2026 | Option exercise | +4,950 | $51.56 | $255.22K | 27,680 |
| Mark S. Bamford VP & Corporate Controller | Feb 17, 2026 | Option exercise | +5,658 | $40.60 | $229.71K | 22,730 |
| Mark S. Bamford VP & Corporate Controller | Feb 17, 2026 | Sale | −19,808 | $97.96 | $1.94M | 7,872 |
| Echevarria Maria Cristina Mendez Director | Feb 15, 2026 | Award | +378 | – | – | 378 |
| Mark S. Bamford VP & Corporate Controller | Feb 13, 2026 | Option exercise | +4,596 | $54.43 | $250.16K | 24,000 |
| Mark S. Bamford VP & Corporate Controller | Feb 13, 2026 | Option exercise | +1,366 | $40.60 | $55.46K | 25,366 |
| Mark S. Bamford VP & Corporate Controller | Feb 13, 2026 | Option exercise | +1,239 | $51.56 | $63.88K | 26,605 |
| Mark S. Bamford VP & Corporate Controller | Feb 13, 2026 | Sale | −9,533 | $98.68 | $940.72K | 17,072 |
| Julie G. Duffy EVP and CHRO | Feb 13, 2026 | Option exercise | +19,857 | $51.56 | $1.02M | 56,896 |
| Julie G. Duffy EVP and CHRO | Feb 13, 2026 | Sale | −19,857 | $98.70 | $1.96M | 37,039 |
| Scott C. Donnelly Executive Chairman, Director | Feb 13, 2026 | Sale | −222 | $99.66 | $22.12K | 742,418 |
| Scott C. Donnelly Executive Chairman, Director | Feb 13, 2026 | Sale | −89,229 | $98.79 | $8.81M | 742,640 |
| Scott C. Donnelly Executive Chairman, Director | Feb 13, 2026 | Sale | −130,168 | $98.15 | $12.78M | 831,869 |
| Scott C. Donnelly Executive Chairman, Director | Feb 13, 2026 | Option exercise | +219,619 | $49.58 | $10.89M | 962,037 |
| Lisa M. Atherton President and CEO, Director | Feb 13, 2026 | Option exercise | +7,600 | $34.50 | $262.20K | 37,073 |
| Lisa M. Atherton President and CEO, Director | Feb 13, 2026 | Sale | −7,600 | $98.68 | $749.97K | 29,473 |
| Lisa M. Atherton President and CEO, Director | Feb 13, 2026 | Gift | −2,532 | – | – | 26,941 |
| E. Robert Lupone EVP, General Counsel & Secy | Oct 27, 2025 | Small purchase | +22.18 | $80.94 | $1.80K | 103,991 |
| Julie G. Duffy EVP and CHRO | Jul 25, 2025 | Gift | −585 | – | – | 37,039 |
| Julie G. Duffy EVP and CHRO | Jul 25, 2025 | Sale | −22,283 | $79.36 | $1.77M | 37,624 |
| Julie G. Duffy EVP and CHRO | Jul 25, 2025 | Option exercise | +22,283 | $40.60 | $904.69K | 59,907 |
| Julie G. Duffy EVP and CHRO | Jul 25, 2025 | Sale | −6,260 | $79.40 | $497.04K | 37,624 |
| Julie G. Duffy EVP and CHRO | Jul 25, 2025 | Option exercise | +6,260 | $49.58 | $310.37K | 43,884 |
| Michael X. Garrett Director | Apr 23, 2025 | Award | +2,794 | – | – | 6,537 |
| Thomas A. Kennedy Director | Apr 23, 2025 | Award | +2,794 | – | – | 7,801 |
| Lionel L. Nowell Iii Director | Apr 23, 2025 | Award | +2,794 | – | – | 18,430 |
| Richard F. Ambrose Director | Apr 23, 2025 | Award | +2,794 | – | – | 9,241 |
| Robert Mionis Director | Apr 23, 2025 | Award | +2,794 | – | – | 3,115 |
| R. Kerry Clark Director | Apr 23, 2025 | Award | +2,794 | – | – | 9,067 |
| Deborah L. James Director | Apr 23, 2025 | Award | +2,794 | – | – | 18,442 |
| Kathleen M. Bader Director | Apr 23, 2025 | Award | +2,794 | – | – | 6,550 |
| Maria T. Zuber Director | Apr 23, 2025 | Award | +2,794 | – | – | 18,446 |
| Mark S. Bamford VP & Corporate Controller | Mar 1, 2025 | Award | +1,492 | – | – | 19,715 |
| Mark S. Bamford VP & Corporate Controller | Mar 1, 2025 | Tax withholding | −326 | $74.73 | $24.36K | 19,389 |
| Robert Mionis Director | Mar 1, 2025 | Award | +321 | – | – | 321 |
| David Mathew Rosenberg Executive Vice President & CFO | Mar 1, 2025 | Award | +6,970 | – | – | 8,151 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Short interest
Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)
Shares sold short, last 12 months
Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of Textron's stock actually held short. Settlement fails (shares not delivered on time) peaked at 117,777 shares on Oct 1, 2026 over the last 90 days.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| R. Kerry Clark Director | May 6, 2026 | 2,517 | $234.31K | May 6, 2026 | Restricted Stock Vesting |
| E. Robert Lupone Officer | Feb 17, 2026 | 28,056 | $2.77M | Feb 17, 2026 | Options Granted - 03/01/2017 |
| Lisa M. Atherton Officer, Director | Feb 13, 2026 | 7,600 | $749.97K | Feb 13, 2026 | Option Granted - 03/01/2016 |
| Julie G. Duffy Officer | Feb 13, 2026 | 19,857 | $1.96M | Feb 13, 2026 | Option Granted 03/01/2021 |
| Scott C. Donnelly Director | Feb 13, 2026 | 219,619 | $21.82M | Feb 13, 2026 | Options Granted - 03/01/2017 |
| Julie G. Duffy Officer | Jul 25, 2025 | 28,543 | $2.27M | Jul 25, 2025 | Option Granted - 03/01/2017 |
| Kathleen M. Bader Director | May 16, 2024 | 2,517 | $220.43K | May 16, 2024 | Restricted Stock Vesting |
| Kathleen M. Bader Officer | May 15, 2024 | 9,353 | $824.75K | May 15, 2024 | Employee Compensation |
| E. Robert Lupone Officer | Feb 21, 2024 | 48,825 | $4.16M | Feb 21, 2024 | Option Granted - 03/01/2016 |
| E. Robert Lupone Officer | Feb 20, 2024 | 8,380 | $713.19K | Feb 20, 2024 | Option Granted - 03/01/2015 |
| Scott C. Donnelly Officer, Director | Feb 15, 2024 | 238,578 | $20.62M | Feb 15, 2024 | Option Granted - 03/01/2016 |
| Frank T. Connor Officer | Feb 15, 2024 | 68,718 | $5.94M | Feb 15, 2024 | Option Granted - 03/01/2016 |
| Julie G. Duffy Officer | Feb 14, 2024 | 12,736 | $1.10M | Feb 14, 2024 | Option Granted - 03/01/2015 |
| Frank T. Connor Officer | Feb 14, 2024 | 56,705 | $4.90M | Feb 14, 2024 | Option Granted - 03/01/2015 |
| Scott C. Donnelly Officer, Director | Feb 14, 2024 | 194,546 | $16.81M | Feb 14, 2024 | Options Granted 03/01/2015 |
Congress trades
12 trades in Textron reported by 6 members of the House
| Member | Type | Traded | Amount | Filed |
|---|---|---|---|---|
| Dan Newhouse WA04 · spouse | Bought | Dec 11, 2025 | $1K–15K | Jan 15, 2026 |
| Lisa McClain MI09 · spouse | Sold | Oct 31, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Bought | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Sold | Oct 30, 2025 | $1K–15K | Nov 21, 2025 |
| Lisa McClain MI09 · spouse | Bought | Aug 4, 2025 | $1K–15K | Sep 12, 2025 |
| Rob Bresnahan PA08 | Sold | Feb 25, 2025 | $1K–15K | Mar 27, 2025 |
| Michael Garcia CA27 | Sold (part) | Jul 12, 2022 | $50K–100K | Aug 23, 2022 |
| Raúl M. Grijalva AZ03 | Sold | Sep 19, 2016 | $1K–15K | Sep 28, 2016 |
| Raúl M. Grijalva AZ03 | Bought | Apr 6, 2016 | $1K–15K | May 4, 2016 |
| Virginia Foxx NC05 · joint account | Sold | Feb 1, 2016 | $15K–50K | Mar 7, 2016 |
| Virginia Foxx NC05 · joint account | Bought | Jul 30, 2015 | $15K–50K | Aug 12, 2015 |
| Virginia Foxx NC05 · joint account | Bought | Apr 28, 2015 | $15K–50K | May 7, 2015 |
See a number that looks wrong?